Research Article

Prediction of Overall Survival and Progression-Free Survival by the 18F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma

Table 3

Univariate analysis (computed tomography).

OSPFS
HR (95%CI) valueHR (95%CI) value

B Symptom (yes vs. no)0.257 (0.042–1.562)0.1400.213 (0.047–0.967)0.045

Histogram based
Kurtosis (≥101.9046 vs.<101.9046)8.399 (1.382–51.043)0.0216.028 (1.091–33.300)0.039

Shape based
Volume (≥47.5887 vs.<47.5887)10.139 (1.131–90.883)0.0386.426 (1.245–33.166)0.026
Sphericity (≥0.6407 vs.<0.6407)6.679 (0.746–59.808)0.09010.157 (1.222–84.413)0.032

GLRLM
HGRE (≥10445.0192 vs.<10445.0192)6.222 (0.684–56.586)0.1059.216 (1.098–77.335)0.041
LRHGE (≥16855.0511 vs.<16855.0511)8.867 (0.985–79.830)0.0525.603 (1.081–29.032)0.040
GLNU (≥880.6339 vs.<880.6339)12.972 (1.448–116.210)0.0228.049 (1.558–41.576)0.013
RLNU (≥4739.7637 vs.<4739.7637)10.139 (1.131–90.883)0.0386.426 (1.245–33.166)0.026

GLZLM
LZE (≥3642.5187 vs.<3642.5187)6.020 (1.003–36.139)0.0505.140 (1.143–23.106)0.033
HGZE (≥10539.0008 vs.<10539.0008)7.330 (1.202–44.687)0.0316.181 (1.365–27.976)0.018
LZLGE (≥0.4211 vs.<0.4211)7.216 (1.190–43.764)0.0326.284 (1.395–28.312)0.017
LZHGE (≥38755329.6111 vs.<38755329.6111)6.020 (1.003–36.139)0.0505.140 (1.143–23.106)0.033
GLNU (≥90.9505 vs.<90.9505)10.139 (1.131–90.883)0.0386.426 (1.245–33.166)0.026
ZP (≥0.1439 vs.<0.1439)0.227 (0.037–1.385)0.1080.195 (0.043–0.885)0.034

HGRE, high gray-level run emphasis; LRHGE, long-run high gray-level emphasis; GLNU, gray-level non-uniformity; RLNU, run length nonuniformity; LZE, long-zone emphasis; HGZE, high gray-level zone emphasis; LZLGE, long-zone low gray-level emphasis; GLRLM, gray-level run length matrix; GLZLM, gray-level zone-length matrix; LZHGE, long-zone high gray-level emphasis; ZP, zone length nonuniformity zone percentage; PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval. Asterisk () indicates significance with a value of <0.05 (shown in bold).